These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [T- and B-lymphocytes and IgG, IgA and IgM level in women with uterine myomas]. Blicharski J; Piotrowski J; Lisiewicz J; Madej J; Bodzoń A; Paruch J; Klimczyk K Ginekol Pol; 1980 Apr; 51(4):325-9. PubMed ID: 6967038 [No Abstract] [Full Text] [Related]
3. [Use of monoclonal antibodies in the study of the lymphoid system. II. Classification and treatment of the leukemias]. Blanco Quirós A; Alvarez Guisasola J An Esp Pediatr; 1982 Jul; 17(1):48-59. PubMed ID: 6982643 [TBL] [Abstract][Full Text] [Related]
4. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system]. Westerhausen M Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157 [TBL] [Abstract][Full Text] [Related]
5. [Immunological surveillance in neoplasms]. Diaz-Rubio García E Rev Clin Esp; 1976 Nov; 143(3):207-18. PubMed ID: 794950 [No Abstract] [Full Text] [Related]
6. Antigens on human plasma cells identified by monoclonal antibodies. Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies]. Kikuchi K Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817 [TBL] [Abstract][Full Text] [Related]
8. [Immunological aspects of the borderline forms of connective tissue diseases]. Go L Ter Arkh; 1974; 46(11):48-58. PubMed ID: 4140579 [No Abstract] [Full Text] [Related]
9. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies. Zipf TF; Fox RI; Dilley J; Levy R Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Greaves MF Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250 [TBL] [Abstract][Full Text] [Related]
11. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens. Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324 [No Abstract] [Full Text] [Related]
13. Enumeration of T and B lymphocytes in whole peripheral blood: absence of a null cell population. Pepys EO; Tennent GA; Pepys MB Clin Exp Immunol; 1981 Oct; 46(1):229-34. PubMed ID: 7039881 [TBL] [Abstract][Full Text] [Related]
14. Optimizing the recovery of chemically reduced monoclonal antibody for site-specific technetium-99m radiolabeling. Boonkitticharoen V; James H; Cheung NK; Larson SM; Finn RD Biotechniques; 1993 May; 14(5):706-8. PubMed ID: 8512684 [No Abstract] [Full Text] [Related]
15. [B cells and serum immunoglobulins in patients with breast pathology]. Zornoza G; Hernández JL; Sanz ML; Fernández J; Goena I; Lera JM Rev Esp Oncol; 1981; 28(1):17-27. PubMed ID: 6984973 [TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies from the hybridization of lymphocytes]. Ax W Ric Clin Lab; 1983; 13 Suppl 2():1-9. PubMed ID: 6366991 [No Abstract] [Full Text] [Related]
17. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody studies in B(non-T)-cell malignancies. Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373 [TBL] [Abstract][Full Text] [Related]
19. Normal and malignant T cells in the regulation of inflammation and immunity. Broder S Agents Actions Suppl; 1980; 7():134-42. PubMed ID: 6454333 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia. Han T; Ozer H; Minowada J Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]